These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6230646)

  • 21. Neonatal herpes simplex virus infection: relapse after initial therapy and transmission from a mother with an asymptomatic genital herpes infection and erythema multiforme.
    Brown ZA; Ashley R; Douglas J; Keilly M; Corey L
    Pediatr Infect Dis J; 1987 Nov; 6(11):1057-61. PubMed ID: 2827097
    [No Abstract]   [Full Text] [Related]  

  • 22. Nature and antigen-specific activities of transfer factor against herpes simplex virus type 1.
    Huang LL; Su CZ; Wan ZF
    Acta Virol; 1987 Nov; 31(6):449-57. PubMed ID: 2449810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of recurrent herpes simplex].
    Eichmann A
    Z Hautkr; 1977 Apr; 52(8):475-82. PubMed ID: 194427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The study of human transfer factor.
    Li ZL
    Sci Sin B; 1985 Apr; 28(4):394-401. PubMed ID: 4012263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of antibodies against herpes simplex virus in patients with oral cancer.
    Kumari TV; Harikumar T; Prabha B; Sasidharan VK; Vasudevan DM
    Indian J Cancer; 1984 Nov-1985 Jan; 21(5-6):137-40. PubMed ID: 6100592
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of herpes simplex skin test in herpetic keratitis. II].
    Kameyama K
    Nippon Ganka Gakkai Zasshi; 1972 Jul; 76(7):392-8. PubMed ID: 4673692
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of a conjugate of staphylococcal protein A with peroxidase in an immunoenzyme test system for determining antibodies to the herpes simplex virus].
    Leonov SV; Posevaia TA; Zakomyrdin IuA; Semenova TB; Dekonenko EP
    Vopr Virusol; 1986; 31(3):321-5. PubMed ID: 3020799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of herpes simplex virus in Syria based on type-specific serological assay.
    Ibrahim AI; Kouwatli KM; Obeid MT
    Saudi Med J; 2000 Apr; 21(4):355-60. PubMed ID: 11533818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally administered specific transfer factor for the treatment of herpes infections.
    Viza D; Vich JM; Phillips J; Rosenfeld F
    Lymphokine Res; 1985; 4(1):27-30. PubMed ID: 4039018
    [No Abstract]   [Full Text] [Related]  

  • 31. Herpes simplex virus antibody in south Indian patients with carcinoma cervix.
    Seshadri L; Seth P; Walter A; Seshadri MS; John TJ
    Indian J Med Res; 1984 Jan; 79():13-8. PubMed ID: 6327511
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the specific humoral immune response in patients with conjunctival herpes simplex virus (HSV) infection].
    Valls de Ruiz M; Igartúa J; Ruiz-Argüelles A
    Rev Invest Clin; 1987; 39(4):339-42. PubMed ID: 2836925
    [No Abstract]   [Full Text] [Related]  

  • 33. BCG immunoprophylaxis of recurrent herpes progenitalis.
    Bierman SM
    Arch Dermatol; 1976 Oct; 112(10):1410-5. PubMed ID: 183605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfer factor in the treatment of herpes simplex types 1 and 2.
    Khan A; Hansen B; Hill NO; Loeb E; Pardue AS; Hill JM
    Dermatologica; 1981; 163(2):177-85. PubMed ID: 6974662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of herpetic antibodies and the herpes simplex virus using new methods].
    Nikulina VG; Khamaganova AV
    Vestn Dermatol Venerol; 1978 May; (5):51-5. PubMed ID: 208323
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nonspecific immune stimulation with BCG in Herpes simplex recidivans. Follow-up 5 to 10 years after BCG vaccination].
    Hippmann G; Wekkeli M; Rosenkranz AR; Jarisch R; Götz M
    Wien Klin Wochenschr; 1992; 104(7):200-4. PubMed ID: 1523844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Depression and Herpex simplex infections].
    Carranza-Acevedo J; Ruiz-Gómez J; Vargas-Rivera J; Bustamante ME
    Arch Invest Med (Mex); 1976; 7(1):17-22. PubMed ID: 1259508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Personal experience with treatment of recurrent herpes infections using combined nonspecific immunostimulation].
    Bystron J; Bohác S; Braunová J; Koukalová D
    Cas Lek Cesk; 1992 Mar; 131(5):137-41. PubMed ID: 1316234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HSV-1 herpes vaccination by LUPIDON H: preliminary results.
    De Maria A; Tundo P; Romano A; Grima P
    Adv Exp Med Biol; 1995; 371B():1599-600. PubMed ID: 7502864
    [No Abstract]   [Full Text] [Related]  

  • 40. Seventeen years of application of herpes vaccines in Bulgaria.
    Dundarov S; Andonov P
    Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.